Dephosphorylation of endothelial nitric-oxide synthase by vascular endothelial growth factor. Implications for the vascular responses to cyclosporin A.
about
Post-translational regulation of endothelial nitric oxide synthase in vascular endotheliumThrombospondin-1 inhibits nitric oxide signaling via CD36 by inhibiting myristic acid uptakePin1 prolyl isomerase regulates endothelial nitric oxide synthaseSignaling regulation of fetoplacental angiogenesisEndothelial caveolar subcellular domain regulation of endothelial nitric oxide synthaseEndothelial nitric oxide synthase in the microcirculation.TNFα reduces eNOS activity in endothelial cells through serine 116 phosphorylation and Pin1 binding: Confirmation of a direct, inhibitory interaction of Pin1 with eNOS.Exercise-induced skeletal muscle remodeling and metabolic adaptation: redox signaling and role of autophagy.Beta 3-adrenoreceptor regulation of nitric oxide in the cardiovascular system.Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunctionNIDD, a novel DHHC-containing protein, targets neuronal nitric-oxide synthase (nNOS) to the synaptic membrane through a PDZ-dependent interaction and regulates nNOS activity.Protein kinase CbetaII-mediated phosphorylation of endothelial nitric oxide synthase threonine 495 mediates the endothelial dysfunction induced by FK506 (tacrolimus).Mechanisms of beta 3-adrenoceptor-induced eNOS activation in right atrial and left ventricular human myocardiumFlow-dependent regulation of endothelial nitric oxide synthase: role of protein kinases.Treatment With Dimethyl Fumarate Attenuates Calcineurin Inhibitor-induced Nephrotoxicity.The COP9 signalosome and vascular function: intriguing possibilities?Suppression of Gαs synthesis by simvastatin treatment of vascular endothelial cellseNOS activation and NO function: structural motifs responsible for the posttranslational control of endothelial nitric oxide synthase activity.Calmodulin phosphorylation and modulation of endothelial nitric oxide synthase catalysis.Role of eNOS phosphorylation at Ser-116 in regulation of eNOS activity in endothelial cells.Ondansetron-related hemorrhagic posterior reversible encephalopathy syndrome (PRES) following gastric bypass.PECAM-1 isoforms, eNOS and endoglin axis in regulation of angiogenesisLife history of eNOS: partners and pathways.Cyclosporine stimulates the renal epithelial sodium channel by elevating cholesterolMaintenance of normal blood pressure is dependent on IP3R1-mediated regulation of eNOS.Tetrahydrobiopterin recycling, a key determinant of endothelial nitric-oxide synthase-dependent signaling pathways in cultured vascular endothelial cells.Calcineurin-mediated dephosphorylation of eNOS at serine 116 affects eNOS enzymatic activity indirectly by facilitating c-Src binding and tyrosine 83 phosphorylation.Role of PTEN in modulation of ADP-dependent signaling pathways in vascular endothelial cells.ADP signaling in vascular endothelial cells: ADP-dependent activation of the endothelial isoform of nitric-oxide synthase requires the expression but not the kinase activity of AMP-activated protein kinase.Interactive effects of in vitro binge-like alcohol and ATP on umbilical endothelial nitric oxide synthase post-translational modifications and redox modulation.Posterior reversible encephalopathy syndrome in children with kidney disease.Tacrolimus associated posterior reversible encephalopathy syndrome - a case series and review.Regulation of eNOS enzyme activity by posttranslational modification.Passive targeting of nanoparticles to cancer: A comprehensive review of the literature.Phosphorylation within an autoinhibitory domain in endothelial nitric oxide synthase reduces the Ca(2+) concentrations required for calmodulin to bind and activate the enzyme.Compartmentalized nitric oxide signaling in the resistance vasculatureCiclosporin to Protect Renal function In Cardiac Surgery (CiPRICS): a study protocol for a double-blind, randomised, placebo-controlled, proof-of-concept studyCalcineurin inhibitors cyclosporine A and tacrolimus induce vascular inflammation and endothelial activation through TLR4 signaling.Reversible posterior encephalopathy syndrome secondary to sunitinib.Inhibition of endothelial nitric oxide synthase by the lipid phosphatase PTEN.
P2860
Q21129237-074C6A6B-7CA5-40B1-83F1-9CC788024AA0Q24302047-2E4D37DE-C9F9-467C-90C3-01BF11B0C6D1Q24617827-9EB4B120-E681-4B1B-B5E1-E16614CDE418Q26825677-D813150A-CAA8-4238-8866-31CDED1E536BQ27009407-0A79F5BA-C867-4FEA-9838-E5E980F09A8CQ30278654-D91E3A85-9AEF-4992-86C9-1E19DBD4D766Q33712286-C271A061-BF0B-4817-A9FD-9057455AA4C9Q33722890-E2F277B3-D9EF-48D4-9329-A42CE4DF3330Q33838174-8EEECE52-2AA9-4191-AFF1-6A9DD4CA0F74Q33920091-D14FB7B2-9E89-4567-B656-51467E8A19D2Q34315882-CD574D5F-4D66-4452-BC88-EFCA568A2C9DQ35003081-041A56A1-9436-493E-B1C0-C16669344E04Q35048451-78E8DEAD-7E29-4C3E-B432-D2493D142787Q35192636-E9B5C56E-E872-4DED-8138-FB82E3953925Q35674764-3BE5AEED-F0FC-4F64-93AA-10BDC2BF47F9Q35700589-BE80CE09-3633-43C5-A742-05EA4F336A8FQ35710014-94F285D6-8AB7-4D4D-8802-45B060F4C59AQ35889758-6CF3E6AF-78E4-40E2-A8DD-ED7455F8A63BQ36016961-83391C38-B291-4952-AB9C-C3811F316CABQ36248991-35A4165E-1A4A-4A14-A31E-304A405E38A9Q36437330-12F69385-7DEF-4429-8F8D-092C0C957226Q36473318-1638CD77-92A3-4BBF-B23E-EB158F161EBFQ36805328-3EE26745-93FB-48EE-A946-34AB3BFC975BQ37100075-B6116793-416E-42B7-B538-B8C473C8C1D5Q37142664-10A44108-D36B-4A92-8A94-01BD2DE2AAEEQ37176379-7045F0B8-B5A4-472C-8C41-0F3CF4F90B3DQ37299501-8C3A9ADB-3A5F-4EE8-A32C-7FCA8AD24169Q37325482-BB339096-1FFF-4D92-A128-B342A5CAD566Q37431885-A8100A26-5D85-4150-AC41-B0730BD6FA79Q37574782-A00333D6-C399-4890-8C50-DF765C3DFFD6Q37589780-F0B52746-2CBC-4CEA-B4A0-3666835EDB90Q37663034-20839CD6-1374-4196-B2DE-99EEAFC2D2EBQ38158116-CC27A3AD-3AEA-4EBF-945D-D7F787D8C3E4Q38256388-00F7359B-047F-46DA-83EB-9B2CD67B7A0CQ38290019-237D36C8-5855-4E95-813F-85FAC3B55DF6Q38509844-7BF0A72A-061B-4FB9-83E0-9BE94E977D89Q39040000-59E72BB2-5C2A-43EB-A46B-D3C5BB381DF2Q39688016-BA713E30-5929-4B5F-8C22-9E7D7CC72B99Q40018027-837F9346-D51E-4AEC-9B94-9AD76A665214Q40173368-3AF41D8A-B69B-407B-AAD3-FE5A791048AF
P2860
Dephosphorylation of endothelial nitric-oxide synthase by vascular endothelial growth factor. Implications for the vascular responses to cyclosporin A.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Dephosphorylation of endotheli ...... ar responses to cyclosporin A.
@en
Dephosphorylation of endotheli ...... ar responses to cyclosporin A.
@nl
type
label
Dephosphorylation of endotheli ...... ar responses to cyclosporin A.
@en
Dephosphorylation of endotheli ...... ar responses to cyclosporin A.
@nl
prefLabel
Dephosphorylation of endotheli ...... ar responses to cyclosporin A.
@en
Dephosphorylation of endotheli ...... ar responses to cyclosporin A.
@nl
P2093
P356
P1476
Dephosphorylation of endotheli ...... ar responses to cyclosporin A.
@en
P2093
Daniel Greif
Thomas Michel
P304
29669-29673
P356
10.1074/JBC.M204519200
P407
P577
2002-06-05T00:00:00Z